We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+43.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$482M
AUM Growth
+$123M
Cap. Flow
+$112M
Cap. Flow %
23.22%
Top 10 Hldgs %
31.91%
Holding
86
New
15
Increased
46
Reduced
9
Closed
16

Top Sells

Rank Stock Value
1
TDG icon
TransDigm Group
TDG
+$8.73M
2
GILD icon
Gilead Sciences
GILD
+$8.12M
3
CTAS icon
Cintas
CTAS
+$5.16M
4
CARS icon
Cars.com
CARS
+$5.12M
5
RICE
Rice Energy Inc.
RICE
+$5.07M

Sector Composition

Rank Sector Weight
1 Financials 20.12%
2 Communication Services 15.86%
3 Healthcare 15%
4 Consumer Discretionary 13.49%
5 Technology 13.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVHC
51
DELISTED
Envision Healthcare Holdings Inc
EVHC
$3.17M 0.66%
91,826
+42,328
+86% +$1.48M
GHDX
52
DELISTED
Genomic Health, Inc.
GHDX
$3.16M 0.65%
92,279
+9,776
+12% +$312K
VNDA icon
53
Vanda Pharmaceuticals
VNDA
$314M
$3.07M 0.64%
202,230
+44,449
+28% +$660K
ASND icon
54
Ascendis Pharma A/S
ASND
$16.8B
$2.96M 0.61%
+73,771
New +$2.68M
NGNE icon
55
Neurogene
NGNE
$738M
$2.95M 0.61%
12,555
+3,041
+32% +$712K
DBVT
56
DBV Technologies
DBVT
$889M
$2.83M 0.59%
11,512
+5,586
+94% +$1.61M
ZBH icon
57
Zimmer Biomet
ZBH
$18.7B
$2.82M 0.58%
24,039
+784
+3% +$88.7K
AET
58
DELISTED
Aetna Inc
AET
$2.75M 0.57%
15,241
-1,077
-7% -$185K
CLVS
59
DELISTED
Clovis Oncology, Inc.
CLVS
$2.72M 0.56%
39,989
+3,460
+9% +$242K
INSM icon
60
Insmed
INSM
$28.9B
$2.72M 0.56%
87,121
-115,292
-57% -$3.41M
HUM icon
61
Humana
HUM
$46.7B
$2.71M 0.56%
10,932
+781
+8% +$193K
EPZM
62
DELISTED
Epizyme, Inc
EPZM
$2.57M 0.53%
204,600
+12,881
+7% +$187K
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$30B
$2.55M 0.53%
20,095
-11,802
-37% -$1.48M
ABMD
64
DELISTED
Abiomed Inc
ABMD
$2.53M 0.53%
13,516
-2,951
-18% -$551K
TGTX icon
65
TG Therapeutics
TGTX
$7.58B
$2.48M 0.52%
+302,761
New +$2.65M
SGEN
66
DELISTED
Seagen Inc. Common Stock
SGEN
$2.45M 0.51%
45,784
-9,535
-17% -$557K
INCY icon
67
Incyte
INCY
$24.5B
$2.36M 0.49%
24,913
+4,797
+24% +$501K
ONCE
68
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.97M 0.41%
+38,371
New +$2.76M
PRTA icon
69
Prothena Corp
PRTA
$475M
$1.75M 0.36%
+46,657
New +$2.38M
VNQ icon
70
Vanguard Real Estate ETF
VNQ
$38.6B
$1.33M 0.28%
16,057
+242
+2% +$20.3K
AMRN
71
Amarin Corp
AMRN
$297M
-40,194
Closed -$2.81M
AXTA icon
72
Axalta
AXTA
$7.98B
-163,822
Closed -$4.74M
CARS icon
73
Cars.com
CARS
$648M
-192,296
Closed -$5.12M
CIEN icon
74
Ciena
CIEN
$61.2B
-192,763
Closed -$4.24M
CSCO icon
75
Cisco
CSCO
$488B
-149,416
Closed -$5.03M

Similar funds

University of Notre Dame du Lac's Q4 2017 Portfolio in Review

As of Q4 2017, University of Notre Dame du Lac held 86 positions worth $482M, up 34% from $359M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

University of Notre Dame du Lac deployed $112M of net new capital in Q4 2017, opening 15 new positions and adding to 46 existing holdings. Its largest new stake was Cornerstone OnDemand, Inc.: 207,151 shares worth $7.32M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Ally Financial, an estimated $3.83M trimmed.

  • University of Notre Dame du Lac's largest Q4 2017 buy was Cornerstone OnDemand, Inc.: 207,151 shares worth $7.32M.
  • University of Notre Dame du Lac added most to Charter Communications in Q4 2017, an estimated $13.6M increase.
  • University of Notre Dame du Lac's biggest Q4 2017 reduction was Ally Financial, cutting an estimated $3.83M.
  • University of Notre Dame du Lac fully exited TransDigm Group in Q4 2017, selling an estimated $8.73M.
  • University of Notre Dame du Lac's ten largest holdings make up 32% of its $482M portfolio in Q4 2017.
  • University of Notre Dame du Lac opened 15 new positions and closed 16 in Q4 2017.
  • University of Notre Dame du Lac's portfolio value rose 34% quarter-over-quarter to $482M.

Based on University of Notre Dame du Lac's 13F filing for Q4 2017, filed 13 Feb 2018.